Current Heart Failure Reports
Scope & Guideline
Fostering Excellence in Cardiology Research
Introduction
Aims and Scopes
- Clinical Management and Treatment Strategies:
The journal explores various therapeutic interventions and management strategies for heart failure, focusing on both pharmacological and non-pharmacological approaches. - Biomarkers and Diagnostic Tools:
A significant emphasis is placed on identifying and validating biomarkers for diagnosing and monitoring heart failure, which aids in tailoring individualized treatment plans. - Multimorbidity and Comorbid Conditions:
Current Heart Failure Reports addresses the complexities of managing heart failure in patients with multiple comorbidities, highlighting the need for a multidisciplinary approach. - Emerging Technologies and Innovations:
The journal covers advancements in technology, including digital health solutions and novel therapeutic modalities, aimed at improving heart failure management. - Sex and Gender Differences:
An ongoing focus on understanding how sex and gender influence heart failure pathophysiology, treatment responses, and outcomes is a hallmark of the journal. - Research on Special Populations:
The journal includes research specifically addressing heart failure in unique populations such as the elderly, pregnant women, and patients with cancer.
Trending and Emerging
- Biomarkers and Precision Medicine:
There is a growing focus on the identification and application of biomarkers for precision medicine in heart failure, allowing for better patient stratification and personalized therapies. - Impact of Comorbidities on Heart Failure:
Emerging research highlights the importance of understanding how comorbid conditions, such as diabetes and cancer, affect heart failure management and patient outcomes. - Digital Health and Telemedicine:
The integration of digital health technologies and telemedicine in managing heart failure is an increasingly prominent theme, especially in light of the COVID-19 pandemic. - Sex and Gender Disparities:
Research addressing sex and gender differences in heart failure is gaining traction, focusing on how these factors influence disease mechanisms, treatment efficacy, and clinical outcomes. - Innovative Therapeutic Approaches:
There is an increasing trend towards exploring novel therapeutic avenues, including gene therapy, cellular therapies, and advanced device technologies for heart failure management. - Mental Health and Heart Failure:
The recognition of mental health's role in heart failure, including depression and anxiety, is an emerging area of focus, emphasizing the need for comprehensive care.
Declining or Waning
- Traditional Risk Factor Management:
Research focusing solely on traditional cardiovascular risk factors (like hypertension and hyperlipidemia) without considering their interplay with heart failure has become less prominent, as the field shifts towards more integrated approaches. - Basic Science Without Clinical Application:
There seems to be a decline in purely basic science studies that do not translate into clinical applications or implications for patient management. - Single-Disease Focus:
The emphasis on heart failure as an isolated condition without considering its relationship with other diseases and comorbidities is waning, as the current research paradigm increasingly appreciates the interconnectedness of health issues.
Similar Journals
Circulation-Heart Failure
Uniting researchers and practitioners in heart failure solutions.Welcome to Circulation-Heart Failure, a leading peer-reviewed journal published by Lippincott Williams & Wilkins dedicated to advancing the field of cardiac biology and clinical cardiology. With an impressive impact factor and ranked in the Q1 category both in Cardiology and Cardiovascular Medicine and in Medicine (miscellaneous), this journal stands out as a vital resource for researchers, clinicians, and students. Since its inception in 2008, Circulation-Heart Failure has been at the forefront of disseminating innovative research, expert reviews, and clinical practices related to heart failure and cardiovascular health. The journal, housed in the United States, is committed to fostering a deeper understanding of heart failure management, offering regular issues that converge comprehensive studies, cutting-edge clinical insights, and the latest advancements in therapeutic strategies. Engage with the latest findings and contribute to the dialogue in a journal recognized for its rigorous standards and significant contributions to the cardiology community.
Radiology-Cardiothoracic Imaging
Innovative Insights for Radiological ExcellenceRadiology-Cardiothoracic Imaging, published by the Radiological Society of North America (RSNA), is a leading peer-reviewed journal dedicated to advancing knowledge in the field of cardiothoracic radiology. With an ISSN of 2638-6135 and a remarkable 2023 Scopus ranking of #5 out of 333 in its category, the journal stands out in the Q1 tier for Radiology, Nuclear Medicine, and Imaging, showcasing its significant impact and high-quality research contributions. The journal is committed to providing an open platform for innovative research, insightful reviews, and clinical studies that address the complexities of cardiothoracic imaging, thereby facilitating the enhancement of diagnostic and therapeutic strategies. Operating out of Oak Brook, Illinois, the journal aims to engage a diverse audience of researchers, professionals, and students, fostering collaboration and knowledge exchange within this vital area of radiological science. With a convergence of years extending from 2019 to 2024, Radiology-Cardiothoracic Imaging remains at the forefront of emerging trends and findings, making it an essential resource for anyone passionate about the evolving landscape of cardiothoracic imaging.
Heart Failure Clinics
Exploring New Frontiers in Heart Failure ManagementHeart Failure Clinics, published by Elsevier Science Inc, stands at the forefront of research and clinical practice in the rapidly evolving field of cardiology and cardiovascular medicine. With an ISSN of 1551-7136, this prestigious journal has established a reputation for high-quality peer-reviewed articles, offering critical insights into heart failure management, innovative therapies, and health care strategies. Ranked in the Q2 quartile for cardiology and cardiovascular medicine and recognized in the Q1 quartile for miscellaneous medicine as of 2023, it reflects a significant impact on both clinical and academic communities, holding a commendable position in the 73rd percentile of its category according to Scopus rankings. Since its inception in 2005, this journal has continuously been a vital resource for researchers, healthcare professionals, and students aiming to enhance their understanding of heart failure. Although it does not offer full open access options, the depth and relevance of its content make it indispensable for anyone engaged in heart health research and practice. Located in the heart of New York, at 230 Park Ave, STE 800, it aims to foster knowledge exchange and promote advancements in cardiovascular care until its converged years in 2024.
Netherlands Heart Journal
Exploring Innovations in Heart Health and Disease ManagementNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
International Journal of Cardiology
Pioneering Discoveries in Cardiovascular MedicineThe International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.
CARDIOLOGY CLINICS
Transforming clinical practice with impactful cardiology research.CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Advancing cardiovascular knowledge for a healthier tomorrow.Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.
Journal of Cardiology
Driving breakthroughs in heart health and patient care.Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.
IJC Heart & Vasculature
Your Gateway to Cutting-Edge Cardiovascular ResearchIJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.
Heart International
Advancing cardiovascular knowledge for a healthier tomorrow.Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.